Cargando…
Mapping of the EQ-5D index from clinical outcome measures and demographic variables in patients with coronary heart disease
BACKGROUND: The EuroQoL 5D (EQ-5D) is a questionnaire that provides a measure of utility for cost-effectiveness analysis. The EQ-5D has been widely used in many patient groups, including those with coronary heart disease. Studies often require patients to complete many questionnaires and the EQ-5D m...
Autores principales: | , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2900231/ https://www.ncbi.nlm.nih.gov/pubmed/20525323 http://dx.doi.org/10.1186/1477-7525-8-54 |
_version_ | 1782183607141400576 |
---|---|
author | Goldsmith, Kimberley A Dyer, Matthew T Buxton, Martin J Sharples, Linda D |
author_facet | Goldsmith, Kimberley A Dyer, Matthew T Buxton, Martin J Sharples, Linda D |
author_sort | Goldsmith, Kimberley A |
collection | PubMed |
description | BACKGROUND: The EuroQoL 5D (EQ-5D) is a questionnaire that provides a measure of utility for cost-effectiveness analysis. The EQ-5D has been widely used in many patient groups, including those with coronary heart disease. Studies often require patients to complete many questionnaires and the EQ-5D may not be gathered. This study aimed to assess whether demographic and clinical outcome variables, including scores from a disease specific measure, the Seattle Angina Questionnaire (SAQ), could be used to predict, or map, the EQ-5D index value where it is not available. METHODS: Patient-level data from 5 studies of cardiac interventions were used. The data were split into two groups - approximately 60% of the data were used as an estimation dataset for building models, and 40% were used as a validation dataset. Forward ordinary least squares linear regression methods and measures of prediction error were used to build a model to map to the EQ-5D index. Age, sex, a proxy measure of disease stage, Canadian Cardiovascular Society (CCS) angina severity class, treadmill exercise time (ETT) and scales of the SAQ were examined. RESULTS: The exertional capacity (ECS), disease perception (DPS) and anginal frequency scales (AFS) of the SAQ were the strongest predictors of the EQ-5D index and gave the smallest root mean square errors. A final model was chosen with age, gender, disease stage and the ECS, DPS and AFS scales of the SAQ. ETT and CCS did not improve prediction in the presence of the SAQ scales. Bland-Altman agreement between predicted and observed EQ-5D index values was reasonable for values greater than 0.4, but below this level predicted values were higher than observed. The 95% limits of agreement were wide (-0.34, 0.33). CONCLUSIONS: Mapping of the EQ-5D index in cardiac patients from demographics and commonly measured cardiac outcome variables is possible; however, prediction for values of the EQ-5D index below 0.4 was not accurate. The newly designed 5-level version of the EQ-5D with its increased ability to discriminate health states may improve prediction of EQ-5D index values. |
format | Text |
id | pubmed-2900231 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2010 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-29002312010-07-09 Mapping of the EQ-5D index from clinical outcome measures and demographic variables in patients with coronary heart disease Goldsmith, Kimberley A Dyer, Matthew T Buxton, Martin J Sharples, Linda D Health Qual Life Outcomes Research BACKGROUND: The EuroQoL 5D (EQ-5D) is a questionnaire that provides a measure of utility for cost-effectiveness analysis. The EQ-5D has been widely used in many patient groups, including those with coronary heart disease. Studies often require patients to complete many questionnaires and the EQ-5D may not be gathered. This study aimed to assess whether demographic and clinical outcome variables, including scores from a disease specific measure, the Seattle Angina Questionnaire (SAQ), could be used to predict, or map, the EQ-5D index value where it is not available. METHODS: Patient-level data from 5 studies of cardiac interventions were used. The data were split into two groups - approximately 60% of the data were used as an estimation dataset for building models, and 40% were used as a validation dataset. Forward ordinary least squares linear regression methods and measures of prediction error were used to build a model to map to the EQ-5D index. Age, sex, a proxy measure of disease stage, Canadian Cardiovascular Society (CCS) angina severity class, treadmill exercise time (ETT) and scales of the SAQ were examined. RESULTS: The exertional capacity (ECS), disease perception (DPS) and anginal frequency scales (AFS) of the SAQ were the strongest predictors of the EQ-5D index and gave the smallest root mean square errors. A final model was chosen with age, gender, disease stage and the ECS, DPS and AFS scales of the SAQ. ETT and CCS did not improve prediction in the presence of the SAQ scales. Bland-Altman agreement between predicted and observed EQ-5D index values was reasonable for values greater than 0.4, but below this level predicted values were higher than observed. The 95% limits of agreement were wide (-0.34, 0.33). CONCLUSIONS: Mapping of the EQ-5D index in cardiac patients from demographics and commonly measured cardiac outcome variables is possible; however, prediction for values of the EQ-5D index below 0.4 was not accurate. The newly designed 5-level version of the EQ-5D with its increased ability to discriminate health states may improve prediction of EQ-5D index values. BioMed Central 2010-06-04 /pmc/articles/PMC2900231/ /pubmed/20525323 http://dx.doi.org/10.1186/1477-7525-8-54 Text en Copyright ©2010 Goldsmith et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Goldsmith, Kimberley A Dyer, Matthew T Buxton, Martin J Sharples, Linda D Mapping of the EQ-5D index from clinical outcome measures and demographic variables in patients with coronary heart disease |
title | Mapping of the EQ-5D index from clinical outcome measures and demographic variables in patients with coronary heart disease |
title_full | Mapping of the EQ-5D index from clinical outcome measures and demographic variables in patients with coronary heart disease |
title_fullStr | Mapping of the EQ-5D index from clinical outcome measures and demographic variables in patients with coronary heart disease |
title_full_unstemmed | Mapping of the EQ-5D index from clinical outcome measures and demographic variables in patients with coronary heart disease |
title_short | Mapping of the EQ-5D index from clinical outcome measures and demographic variables in patients with coronary heart disease |
title_sort | mapping of the eq-5d index from clinical outcome measures and demographic variables in patients with coronary heart disease |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2900231/ https://www.ncbi.nlm.nih.gov/pubmed/20525323 http://dx.doi.org/10.1186/1477-7525-8-54 |
work_keys_str_mv | AT goldsmithkimberleya mappingoftheeq5dindexfromclinicaloutcomemeasuresanddemographicvariablesinpatientswithcoronaryheartdisease AT dyermatthewt mappingoftheeq5dindexfromclinicaloutcomemeasuresanddemographicvariablesinpatientswithcoronaryheartdisease AT buxtonmartinj mappingoftheeq5dindexfromclinicaloutcomemeasuresanddemographicvariablesinpatientswithcoronaryheartdisease AT sharpleslindad mappingoftheeq5dindexfromclinicaloutcomemeasuresanddemographicvariablesinpatientswithcoronaryheartdisease |